Participants 96 228 7
healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion
Participants 1388 1404 5
healthy subjects
Participants 1409 1510 5
asymptomatic porphobilinogen deaminase-deficient subjects with high concentrations of porphobilinogen
Participants 1569 1806 7
Forty individuals participated in this two-part study: 20 asymptomatic porphobilinogen deaminase-deficient subjects (both male and female) with > or =4 times the upper reference urinary porphobilinogen level, and 20 healthy male subjects
Participants 1925 2173 3
Part A included 12 asymptomatic porphobilinogen deaminase-deficient subjects, and the enzyme was administered in an open-label, single-dose design. Part B included 20 asymptomatic porphobilinogen deaminase-deficient subjects and 20 healthy subjects
Participants 4718 4760 3
patients with acute intermittent porphyria
